04.02.19

Bausch + Lomb Announces US Launch of Lotemax SM

Source: Bausch + Lomb

02.25.19

FDA Approves Bausch + Lomb’s Lotemax SM For The Treatment Of Postoperative Inflammation And Pain

Source: Bausch + Lomb

02.19.19

Bausch + Lomb Acquires Eton Pharmaceuticals’ EM-100 Investigational OTC Eye Drop For Allergic Conjunctivitis

Source: Bausch Health Companies

02.13.19

Bausch + Lomb Receives 510(k) Clearance For Use Of The Tangible Hydra-PEG Custom Contact Lens Coating

Source: Bausch + Lomb

02.04.19

Bausch + Lomb Launches Sightmatters.com to Help People Living With AMD

Source: Bausch + Lomb

01.30.19

Bausch Health Reduces Debt By Additional $100 Million

Source: Bausch Health Companies

01.22.19

Bausch + Lomb Introduces Zen Multifocal Scleral Lens for Presbyopia

Source: Bausch + Lomb

01.03.19

Bausch + Lomb Announces Health Canada Approval Of Vyzulta for the Treatment of Glaucoma

Source: Bausch + Lomb

12.06.18

Bausch + Lomb Receives FDA Clearance For Ultra Multifocal For Astigmatism Contact Lenses

Source: Bausch + Lomb

12.04.18

Bausch + Lomb Announces Exclusive Agreement with Modulight to Develop New Photodynamic Laser

Source: Bausch + Lomb

View more stories